Critics Assail J&J’s Sponsorship Of High-Profile Physician Conference Exploring Conflict Of Interests

Johnson & Johnson is underwriting the conference scheduled for June. “The pharmaceutical sponsorship is a problem for a conference on this topic. We need to extract medical research, education, and practice from the all-pervasive and distorting influence of industry,” said Fiona Godlee, the editor-in-chief of BMJ, who rejected an invitation to appear as a panelist. Physician news is also on consolidated practices.

from Kaiser Health News https://ift.tt/2PvZytV